138 related articles for article (PubMed ID: 1463339)
1. [Chemotherapy for advanced pancreatic carcinoma].
Yokoyama T; Shimada Y
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2338-43. PubMed ID: 1463339
[TBL] [Abstract][Full Text] [Related]
2. [A current overview of chemotherapy in advanced gastric cancer].
Ogawa M
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2161-8. PubMed ID: 2660747
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of cancer of the exocrine pancreas].
Bonneterre J
Bull Cancer; 1990; 77(3):267-74. PubMed ID: 2140281
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of pancreatic cancer].
Yoshimori M; Tajiri H; Nakamura K; Ozaki H
Gan To Kagaku Ryoho; 1985 Feb; 12(2):227-34. PubMed ID: 3155930
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
6. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
7. FAM chemotherapy +/- aminoglutethimide in the treatment of pancreatic carcinoma.
Lipton A; Harvey HA; Santen RJ; Stryker JA; Barnes SG; Walker BK; Dixon RH; Givant EM; Bartholomew MJ; Nadjafi C
Eur J Surg Oncol; 1990 Feb; 16(1):12-4. PubMed ID: 2307239
[TBL] [Abstract][Full Text] [Related]
8. [Cisplatin, adriamycin and cyclophosphamide combination chemotherapy of epithelial ovarian cancer].
Sawada M; Ozaki M; Inagaki M; Hongo J; Hirota Y; Takayama K; Arimoto Y; Wada T; Taki I; Yanagita T
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3301-4. PubMed ID: 3120644
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of hormonally unresponsive prostatic carcinoma.
deKernion JB; Lindner A
Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.
Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS
Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982
[No Abstract] [Full Text] [Related]
11. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of advanced gastric cancer: present status, future prospects.
Macdonald JS; Gohmann JJ
Semin Oncol; 1988 Jun; 15(3 Suppl 4):42-9. PubMed ID: 3293218
[TBL] [Abstract][Full Text] [Related]
13. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
[TBL] [Abstract][Full Text] [Related]
14. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
Kelsen D
Semin Oncol; 1994 Aug; 21(4 Suppl 7):58-66. PubMed ID: 8091242
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
Dunst J; Haensgen G
Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
[TBL] [Abstract][Full Text] [Related]
16. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of pancreatic cancer is not yet generally recommended].
Hartwich G
Med Klin; 1980 Aug; 75(16):575-9. PubMed ID: 6447832
[No Abstract] [Full Text] [Related]
18. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; DiƩras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
19. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK
Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742
[TBL] [Abstract][Full Text] [Related]
20. [Prospective randomized trial comparing modified FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus 5-FU alone for the treatment of non-resectable pancreatic and biliary tract carcinomas (the 1st trial in non-resectable patients). Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
Takada T; Kato H; Sasaki M; Matsushiro T; Yamauchi H; Kajihara T; Watanabe G; Hanaue H; Yoshida K; Shimizu T
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1295-301. PubMed ID: 1503483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]